These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 117305)

  • 1. [Breast neoplasms. Importance of histology and prognosis for the treatment planning].
    Prechtel K
    MMW Munch Med Wochenschr; 1979 Sep; 121(38):1203-7. PubMed ID: 117305
    [No Abstract]   [Full Text] [Related]  

  • 2. It is not time to stop progesterone receptor testing in breast cancer.
    Colomer R; Beltran M; Dorcas J; Cortes-Funes H; Hornedo J; Valentin V; Vargas C; Mendiola C; Ciruelos E
    J Clin Oncol; 2005 Jun; 23(16):3868-9; author reply 3869-70. PubMed ID: 15923595
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic factors and therapeutic protocol].
    Serment H; Piana L
    J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):209-20. PubMed ID: 670643
    [No Abstract]   [Full Text] [Related]  

  • 4. Time to stop progesterone receptor testing in breast cancer management.
    Olivotto IA; Truong PT; Speers CH; Bernstein V; Allan SJ; Kelly SJ; Lesperance ML
    J Clin Oncol; 2004 May; 22(9):1769-70. PubMed ID: 15118010
    [No Abstract]   [Full Text] [Related]  

  • 5. [Infraclavicular exploration as a prognostic criterion and as a selection criterion for choice of treatment in breast cancer].
    van Dongen JA; van Slooten EA
    Ned Tijdschr Geneeskd; 1983 Apr; 127(17):714-7. PubMed ID: 6855952
    [No Abstract]   [Full Text] [Related]  

  • 6. Rationale for routine axillary dissection in carcinoma of the breast.
    Ruffin WK; Stacey-Clear A; Younger J; Hoover HC
    J Am Coll Surg; 1995 Feb; 180(2):245-51. PubMed ID: 7850065
    [No Abstract]   [Full Text] [Related]  

  • 7. [Infraclavicular lymph node biopsy in the treatment of breast cancer].
    Styblo K; Kluft O; de la Fuente AA
    Ned Tijdschr Geneeskd; 1983 Apr; 127(17):718-20. PubMed ID: 6855953
    [No Abstract]   [Full Text] [Related]  

  • 8. Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology?
    Mendez JE; Fey JV; Cody H; Borgen PI; Sclafani LM
    Ann Surg Oncol; 2005 Jan; 12(1):24-8. PubMed ID: 15827774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the purpose of cancer staging?
    Morrow M
    Breast; 2006 Feb; 15(1):1-2. PubMed ID: 16413187
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comprehensive treatment of breast cancer].
    Datsenko VS
    Vopr Onkol; 1979; 25(4):54-8. PubMed ID: 433219
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic factors for breast cancer and their use in the clinical setting.
    Kapoor A; Vogel VG
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):269-81. PubMed ID: 15877524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sentinel lymph node reevaluation].
    Siewert JR
    Chirurg; 2004 Aug; 75(8):749-50. PubMed ID: 15515215
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of the pathologist in the staging-controlled therapy of breast cancer].
    Stegner HE
    Pathologe; 1982 May; 3(3):137-48. PubMed ID: 7111217
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of risk and prognostic factors in treatment planning and treatment control in metastasizing tumors].
    Nagel GA; Nagel-Studer E
    Verh Dtsch Ges Inn Med; 1980; 86():388-99. PubMed ID: 7223031
    [No Abstract]   [Full Text] [Related]  

  • 15. The multidisciplinary approach a need in optimal management of breast cancer.
    Maricić Z; Nola P; Kolarić K
    Arch Geschwulstforsch; 1980; 50(6):563-8. PubMed ID: 7224812
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
    Tez M; Tez S
    Cancer; 2005 Oct; 104(8):1779-80; author reply 1780. PubMed ID: 16104028
    [No Abstract]   [Full Text] [Related]  

  • 17. Future prospects for the staging of breast cancer.
    Rutgers EJ; Peterse HL
    Semin Surg Oncol; 1996; 12(1):3-11. PubMed ID: 8821404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of radiation therapy in the complex treatment of breast cancer].
    Pavlov AS; Datsenko VS
    Vopr Onkol; 1978; 24(8):48-54. PubMed ID: 695426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors in breast cancer with negative lymph nodes].
    Albanell Mestres J; Bellmunt Molins J; Solé Calvo LA
    Med Clin (Barc); 1992 Nov; 99(17):668-74. PubMed ID: 1447940
    [No Abstract]   [Full Text] [Related]  

  • 20. The significance of intramammary nodes in primary breast cancer.
    Upponi S; Kalra S; Poultsidis A; Bobrow L; Purushotham AD
    Eur J Surg Oncol; 2001 Dec; 27(8):707-8. PubMed ID: 11735164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.